RCA Telegram News California - News from San Francisco, California, the USA and the world, around the clock every day

Amdocs Announces First Quarter Fiscal 2027 Investor Conference Schedule
Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026
Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026

DENVER, CO / ACCESS Newswire / November 10, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its fiscal 2027 first quarter after the market close on Monday, November 16, 2026. The Company has scheduled a conference call and webcast that same day, Monday, November 16, 2026, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.

November 10, 2026

RECENT NEWS

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax

Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months ended September 30, 2026 compared to same periods last yearNet loss per share improved 97% for the quarter and 92% for the six months ended September 30, 2026 compared to same periods last yearNet income before taxes of $382,000 for the quarter and $52,000 for the six months ended September 30, 2026

November 10, 2026

Gladstone Land Announces Third Quarter 2026 Results
Gladstone Land Announces Third Quarter 2026 Results

Please note that the limited information that follows in this press release is a summary and is not adequate for making an informed investment decision.

November 10, 2026

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Third Quarter 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Third Quarter 2026

- Dermata generates product revenue following the launch of its first commercial product,Tome™ Foundational Treatment, on August 25, 2026 -- Tome Skincare ecommerce platform establishes a foundation for product growth through direct-to-consumer sales, subscriptions, and professional skincare channels -- Positive topline results from a cosmetic clinical study in which participants demonstrated improvements across multiple measures of skin appearance provides clinical support for the commercialization strategy of Tome Foundational Treatment as "Studied Skincare" -

November 10, 2026

RECENT NEWS

ParkerVision Reports Third Quarter 2026 Results
ParkerVision Reports Third Quarter 2026 Results

JACKSONVILLE, FL / ACCESS Newswire / November 10, 2026 / ParkerVision, Inc. (OTCQB:PRKR) ("ParkerVision" or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the nine months ended September 30, 2026.

November 10, 2026

RECENT NEWS

Golden Minerals Announces Completion of Offering for C$5,000,000
Golden Minerals Announces Completion of Offering for C$5,000,000

DENVER, CO / ACCESS Newswire / November 10, 2026 / Golden Minerals Company ("Golden Minerals," "Golden" or the "Company") (TSX:AUMN)(OTCQB:AUMN) is pleased to announce the closing of its previously announced non-brokered private placement (the "Offering") pursuant to which the Company has issued 17,857,143 units of the Company (each a "Unit") at a price of C$0.28 per Unit for gross proceeds of C$5,000,000.

November 10, 2026